PHILADELPHIA, PA (June 14, 2011) - On June 15, the Lymphoma Research Foundation (LRF), in collaboration with the John Theurer Cancer Center at Hackensack University Medical Center, will bring together lymphoma experts to discuss the latest practices in the diagnosis and management of lymphoma. This event is the final installation of LRF's 2010-2011 Philadelphia Lymphoma Rounds program, a continuing medical education (CME) series focused on the diagnosis and treatment of lymphoma patients.
"The Philadelphia Lymphoma Round Program is an opportunity for clinicians to better understand the latest lymphoma treatment advancements and apply these findings to their practice," said Anthony Mato, M.D., Program Chair and Lymphoma Attending at the John Theurer Cancer Center. "The treatment of lymphoma is rapidly changing, and we are committed to forums like this to keep the latest information accessible to physicians across the country."
The Lymphoma Rounds program provides a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by local lymphoma experts. The Philadelphia Lymphoma Rounds program is chaired by Stephen Schuster, M.D., Associate Professor of Medicine at the University of Pennsylvania.
"Lymphoma Rounds are an integral part of the Lymphoma Research Foundation's professional education services," said Brian Tomlinson, LRF's Chief Program Officer. "We are thrilled to work with the John Theurer Cancer Center for the final Philadelphia Lymphoma Rounds program of the 2010-2011 year, and to enable attendees to benefit from the collaboration of lymphoma experts from the leading Philadelphia-area institutions."
This program is free for healthcare professionals; however, pre-registration is required and available online. The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.5 AMA PRA Category I Credit.
Food and refreshments will be provided for all registered participants. The event will be held at the Philadelphia Westin Hotel, 99 South 17th Street, Philadelphia, PA. For additional information, please contact Max Mulcahy at the Lymphoma Research Foundation at email@example.com or register for the event at www.lymphoma.org/PLR.
The Lymphoma Research Foundation is presenting this meeting in collaboration with the John Theurer Cancer Center, Cooper University Hospital, Fox Chase Cancer Center, Helen F. Graham Cancer Center, Thomas Jefferson University, and University of Pennsylvania, and Vita Medical Associates. The complete 2011-2012 Lymphoma Rounds program schedule will be available in the Fall.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease.
LRF remains dedicated to finding a cure for lymphoma through an aggressively-funded research program and by supporting the development of improved therapies for people living with lymphoma. To date, the Foundation has funded more than $40 million in lymphoma-specific research. The Foundation also provides a comprehensive series of programs and services for people with lymphoma, their loved ones and caregivers.
For additional information on LRF's programs and services, visit www.lymphoma.org.
About the John Theurer Cancer Center at Hackensack University Medical Center
The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 14 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within a 775-bed not-for-profit teaching, tertiary care, and research hospital, the John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of after care services that distinguish the John Theurer Cancer Center from other facilities. For more information please go to jtcancercenter.org.